Specifically, SHANK3 plays a pivotal role in regulating glutamatergic synapses, maturation of the dendritic spine, and strengthening the formation and transmission of synapses via glutamate receptors such as AMPARs and NMDARs
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Discover how glutathione injections can rejuvenate skin, reduce wrinkles, and even out complexion for a youthful appearance
For therapeutic goods, always read the label and follow the directions for use on pack
